Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.

Affiliation

Department of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, 666-2 Nitona-cho, Chuo-ku, Chiba-shi, Chiba 260-8717, Japan. Electronic address: [Email]

Abstract

The relevance of patient-derived cancer cells has been recently increasing, particularly in terms of drug discovery and precision medicine. Whereas Matrigel-based organoid culture is a promising technique that enables infinite proliferation of cells from many types of organs in a physiological condition, its validity in gynecologic tumors remains to be established. To address this issue, we aimed at developing an efficient method for organoid culture of both ovarian and endometrial tumors.

Keywords

Endometrial cancer,Next-generation sequencing,Organoid,Ovarian cancer,Preclinical model,Tumor heterogeneity,